Search

Displaying results 5231 - 5240 of 7479 in total
  1. Drug

    ALT-P1

    go.drugbank.com/drugs/DB18485
    Investigational

    ALT-P1 is a long-acting recombinant human growth hormone fused to an alpha1-antitrypsin variant. It is under investigation for the treatment of growth hormone deficiency.

  2. Drug

    Abetimus

    go.drugbank.com/drugs/DB06662
    Investigational

    Abetimus was developed by La Jolla Pharmaceuticals as an immunosuppressant but was never marketed in American or Europe despite application for marketing authorization in the mid-2000s.

  3. Drug

    Pelitinib

    go.drugbank.com/drugs/DB05524
    Investigational

    Pelitinib (EKB-569) is a potent, low molecular weight, selective, and irreversible inhibitor of epidermal growth factor receptor (EGFR) that is being developed as an anticancer agent.

  4. Drug

    Asvasiran

    go.drugbank.com/drugs/DB05638
    Investigational

    Asvasiran is an siRNA that targets the respiratory syncytial virus (RSV) N gene and inhibits viral replication. It has the potential to treat or prevent RSV infection.

  5. Drug

    Staurosporine

    go.drugbank.com/drugs/DB02010
    Experimental

    An indolocarbazole that is a potent protein kinase C inhibitor which enhances cAMP-mediated responses in human neuroblastoma cells. (Biochem Biophys Res Commun 1995;214(3):1114-20)

  6. Drug

    Leukotriene D4

    go.drugbank.com/drugs/DB11858
    Investigational

    Leukotriene D4 has been used in trials studying the diagnostic of Asthma and Allergic Rhinitis.

    Synonyms: Leukotriene D4
  7. Drug

    Clogestone

    go.drugbank.com/drugs/DB19526
    Experimental

    Clogestone has a monoisotopic molecular weight of 364.18 Da.

  8. Drug

    Volpristin

    go.drugbank.com/drugs/DB19604
    Experimental

    Volpristin has a monoisotopic molecular weight of 527.26 Da.

  9. Drug

    Spirogermanium

    go.drugbank.com/drugs/DB19618
    Experimental

    Spirogermanium has a monoisotopic molecular weight of 342.21 Da.

  10. Drug

    Nivimedone

    go.drugbank.com/drugs/DB19631
    Experimental

    Nivimedone has a monoisotopic molecular weight of 219.05 Da.